What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the estimated listing price for Nidan Laboratories and Healthcare Limited IPO?

Based on the upper price band of ₹125 and current GMP of ₹0, the estimated listing price is ₹125 (approx. 0.0% gain).

What is the expected profit per lot for Nidan Laboratories and Healthcare Limited IPO?

With a lot size of 1000 shares and current GMP of ₹0, expected profit per retail application lot is approximately ₹0.

IPO GreyPremiumLIVE

Grey Market Intelligence

Nidan Laboratories and Healthcare Limited

ListedSME

Healthcare · NSE

Incorporated in 2000, Nidan Laboratories and Healthcare Limited provides a wide range of diagnostic services including pathology, radiology, neurology, cardiology, and dental care. The company offers hundreds of routine and specialized pathology and radiology tests, covering everything from basic blood tests and X-rays to advanced molecular diagnostics, CT scans, and MRI scans, along with customized health packages and services like home sample collection and digital report delivery. Nidan operates diagnostic and collection centers under its brand, supported by its own appointment-booking mobile app and management software, partners with established pathology labs, employs over 200 people, and has received industry recognition for its diagnostic services.

Price Band

₹125

Issue Size

₹50.00 Cr

Lot Size

1000 shares

GMP

—

Est. Listing

₹125

at current GMP

Subscribed

—

Open

28 Oct 2021

2 Nov 2021

Allotment

9 Nov 2021

Refund

10 Nov 2021

Demat Credit

11 Nov 2021

Listing

12 Nov 2021

Last updated 12 days ago

Overview Live GMP Live Subscription Allotment Status

Live Grey Market Premium

Nidan Laboratories and Healthcare Limited GMP Today

Last updated: 19 Oct 2026

Current Premium

₹00.0%

Issue Price (Upper)

₹125

Band: ₹125

Estimated Listing Price

₹125

Upper price + GMP

Lot Size

1000 shares

Min investment ₹1,25,000

Date	GMP (₹)	GMP %	Est. Listing
31 Oct 2026	—	0.0%	₹125
30 Oct 2026	—	0.0%	₹125
29 Oct 2026	—	0.0%	₹125

About Nidan Laboratories and Healthcare Limited Public Issue & Market Profile

Nidan Laboratories and Healthcare Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹50 Crores. The shares are offered at a price band of ₹125 to ₹125 per equity share on NSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.

Public Issue & Pricing Context:

Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1000 shares (approx. ₹1,25,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.

Basis of Allotment & Listing Timeline:

Allotment reconciliation will be managed by Bigshare Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2021-11-11, while un-allotted funds or UPI block mandates will be released on 2021-11-10.

Frequently Asked Questions

What is Nidan Laboratories and Healthcare Limited IPO GMP today?

The latest grey market premium for Nidan Laboratories and Healthcare Limited IPO is ₹0, which indicates an expected listing price of ₹125.

What does Kostak Rate and Sauda mean in IPO GMP?

Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.

Is Grey Market Premium officially recognized?

No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.

Nidan Laboratories and Healthcare Limited

Nidan Laboratories and Healthcare Limited GMP Today

Nidan Laboratories and Healthcare Limited GMP Historical Trend

GMP History

Estimated Listing Price

About Nidan Laboratories and Healthcare Limited Public Issue & Market Profile

Frequently Asked Questions

What is Nidan Laboratories and Healthcare Limited IPO GMP today?

What does Kostak Rate and Sauda mean in IPO GMP?

Is Grey Market Premium officially recognized?